Found 20 matching trials
A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia PHASE3 The purpose of the study is to evaluate the safety, tolerability and treatm...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate in Rwandan Healthcare Facilities PHASE4 The purpose of this study is to evaluate the feasibility of conducting a st...
Show More Location
CARAES Ndera Neuro-Psychiatric Hospital
Learn More & Join Trial
A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia PHASE3 The purpose of this study is to compare the effectiveness and safety over 1...
Show More Location
Multiple Locations
Learn More & Join Trial
Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia PHASE3 The primary objectives of this study are to evaluate the efficacy and safet...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With Schizophrenia PHASE3 The purpose of this study is to determine the efficacy (how well the drug w...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare Settings PHASE4 The purpose of this study is to assess the long-term symptomatic response (...
Show More Location
University Teaching Hospital of Butare(CHUB)
Learn More & Join Trial
A Study to Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With Schizophrenia PHASE3 The purpose of this study is to evaluate the effectiveness and safety of 3 ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Comparative Study of Paliperidone Palmitate and Risperidone Long Acting Injection (LAI) in Participants With Schizophrenia PHASE3 The purpose of this study is to compare the efficacy of paliperidone palmit...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia PHASE3 The purpose of this study is to demonstrate the effectiveness of paliperido...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia. PHASE3 The purpose of this study is to evaluate the efficacy of paliperidone palmi...
Show More Location
Multiple Locations
Learn More & Join Trial